BOLT BIOTHERAPEUTICS INC (BOLT) Stock Analyst Ratings
NASDAQ:BOLT - Nasdaq - US0977021049 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 49% to BOLT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.15. This target is 264.75% above the current price.
BOLT was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about BOLT.
In the previous month the buy percentage consensus was at a similar level.
BOLT was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-20 | Lake Street | Initiate | Buy |
| 2025-05-13 | Stifel | Maintains | Hold -> Hold |
| 2025-03-25 | Stifel | Maintains | Hold -> Hold |
| 2025-03-25 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-05-15 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-05-15 | Jones Trading | Downgrade | Buy -> Hold |
| 2024-05-15 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-05-15 | Stifel | Downgrade | Buy -> Hold |
| 2024-05-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-03-22 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-06-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-26 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-12 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-30 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-01-24 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-10-04 | HC Wainwright & Co. | Initiate | Buy |
| 2022-08-11 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-05-17 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-01-06 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2021-11-10 | SVB Leerink | Maintains | Outperform |
| 2021-08-16 | SVB Leerink | Maintains | Outperform |
| 2021-05-17 | SVB Leerink | Maintains | Outperform |
| 2021-04-06 | SVB Leerink | Maintains | Outperform |
| 2021-03-02 | Guggenheim | Initiate | Buy |
| 2021-03-02 | SVB Leerink | Initiate | Outperform |